Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03562741 · ClinicalTrials.gov registry record · NA
Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile
A NA study of Clostridium Difficile Infection and Clostridium Difficile Infection Recurrence, sponsored by Krunal Patel.
- Recruiting
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT03562741: Recruiting NA study of Clostridium Difficile Infection and Clostridium Difficile Infection Recurrence, sponsored by Krunal Patel.
NCT03562741 is a NA study of Clostridium Difficile Infection and Clostridium Difficile Infection Recurrence that is actively recruiting participants, run by Krunal Patel. The registered enrollment target is 500 participants, below the 12,027-participant average among 13 other Clostridium Difficile Infection trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03562741, a NA study of Clostridium Difficile Infection and Clostridium Difficile Infection Recurrence, is actively recruiting participants, sponsored by Krunal Patel.
- RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see if stool transplant performed by colonoscopy is effective at treating recurrent Clostridium difficile (C. diff) infection of the colon. During the procedure a stool sample is taken from a healthy donor (usually family member or close friend) and transplanted directly into the colon of the patient with C. diff infection. The goal of this experimental procedure (called fecal microbiota transplantation) is to replenish the good bacteria in the colon that can help prevent C. diff infection from coming back after treatment.
Primary Outcome
Longterm resolution of C. diff associated diarrhea after Fecal Microbiota Transplantation (FMT) therapy
Conditions Studied
Interventions
- PROCEDURE Fecal Microbiota Transplantation
Study Locations (1)
Massachusetts
- UMass Memorial Medical Center - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2014-01-16 |
| Est. Completion | 2029-01-16 |
| Phase | NA |
What NCT03562741 shows while recruiting
NCT03562741 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 12,027-participant average among 13 other Clostridium Difficile Infection trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Clostridium Difficile Infection appearing as the primary indexed condition, and to 1 intervention - of which Fecal Microbiota Transplantation is the first listed.
NCT03562741 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03562741 about?
NCT03562741 is a clinical study titled "Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile". The purpose of this study is to see if stool transplant performed by colonoscopy is effective at treating recurrent Clostridium difficile (C. diff) infection of the colon. During the procedure a stool sample is taken from a healthy donor (usually family member or close friend) and transplanted direc...
What is the current status of trial NCT03562741?
This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2014-01-16. Estimated completion is 2029-01-16.
What conditions does trial NCT03562741 study?
This clinical trial studies the following conditions: Clostridium Difficile Infection, Clostridium Difficile Infection Recurrence.
What interventions are being tested in trial NCT03562741?
The interventions under investigation include: Fecal Microbiota Transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT03562741?
This trial is sponsored by Krunal Patel, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03562741 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Clostridium Difficile Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03562741's enrollment target sits among peer trials
500 4th of 13 higher than 10 of 13 other Clostridium Difficile Infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Clostridium Difficile Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fecal Microbiota Transplantation for C Diff Infection
RECRUITING · NA
-
Validation of the GenePOC CDiff Assay for the Detection of the Toxin B Gene From Toxigenic Clostridium Difficile Strains
COMPLETED · NA
-
Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)
RECRUITING · Phase 2
-
Fecal Microbiota Transplant National Registry
RECRUITING
-
Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infection in Critically Ill Patients
RECRUITING · Phase 2
-
Protocol for Admission Toxigenic C. Difficile Surveillance
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI